Clinical Trial Site

Albuquerque, New Mexico 87109

1 studies enrolling now · 5 studies all time

What they study most

Amyloidosis, High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension, Iron Deficiency Anemia, Leukocyte Chemotactic Factor 2 Amyloidosis

Studies at this site

• Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease — Recruiting now
• Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3) — Completed
• A Trial Comparing Ferumoxytol With Placebo for the Treatment of Iron Deficiency Anemia — Completed
• A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia — Completed
• A Study of the Natural History of Leukocyte Chemotactic Factor 2 Amyloidosis (ALECT2) Disease — Stopped early